GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Cash per Share

Theragen Etex Co (XKRX:066700) Cash per Share : ₩755.60 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Theragen Etex Co's Cash per Share for the quarter that ended in Dec. 2024 was ₩755.60.


Theragen Etex Co Cash per Share Historical Data

The historical data trend for Theragen Etex Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Cash per Share Chart

Theragen Etex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 495.61 425.00 669.31 727.40 755.60

Theragen Etex Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 727.40 696.95 797.69 880.24 755.60

Theragen Etex Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Theragen Etex Co's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Theragen Etex Co's Cash per Share for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theragen Etex Co  (XKRX:066700) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Theragen Etex Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Theragen Etex Co Business Description

Traded in Other Exchanges
N/A
Address
58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines